PAK6: a potential anti-cancer target
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/182720 |
Resumo: | p21-activated kinase 6 (PAK6) is a member of the PAK family of serine/threonine kinases that are known effectors of Rho GTPases Cdc42 and Rac. PAKs regulate a large number of complex cellular mechanisms, including cell motility, morphology, and tumor development. PAK6, initially cloned as an interacting partner of the androgen receptor (AR), is associated with an array of cellular processes implicated in tumor progression. However, the full biological implications of PAK6 activity during cancer remain poorly understood. In this review, we assess our current understanding of the physiological roles of classical PAK6 functionality in mammals, in addition to its emerging role in tumorigenesis. |
id |
USP-31_963dbdb4ef3f6fd0a18015064988f4de |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/182720 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
PAK6: a potential anti-cancer targetPAK6androgen Receptor (AR)cancer therapymiRNAsp21-activated kinase 6 (PAK6) is a member of the PAK family of serine/threonine kinases that are known effectors of Rho GTPases Cdc42 and Rac. PAKs regulate a large number of complex cellular mechanisms, including cell motility, morphology, and tumor development. PAK6, initially cloned as an interacting partner of the androgen receptor (AR), is associated with an array of cellular processes implicated in tumor progression. However, the full biological implications of PAK6 activity during cancer remain poorly understood. In this review, we assess our current understanding of the physiological roles of classical PAK6 functionality in mammals, in addition to its emerging role in tumorigenesis.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18272010.1590/s2175-97902019000318315Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18315Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18315Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e183152175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/182720/169583Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGong, Chan-Chan Li, Tong-Tong Pei, Dong-Sheng 2021-06-12T19:46:54Zoai:revistas.usp.br:article/182720Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
PAK6: a potential anti-cancer target |
title |
PAK6: a potential anti-cancer target |
spellingShingle |
PAK6: a potential anti-cancer target Gong, Chan-Chan PAK6 androgen Receptor (AR) cancer therapy miRNAs |
title_short |
PAK6: a potential anti-cancer target |
title_full |
PAK6: a potential anti-cancer target |
title_fullStr |
PAK6: a potential anti-cancer target |
title_full_unstemmed |
PAK6: a potential anti-cancer target |
title_sort |
PAK6: a potential anti-cancer target |
author |
Gong, Chan-Chan |
author_facet |
Gong, Chan-Chan Li, Tong-Tong Pei, Dong-Sheng |
author_role |
author |
author2 |
Li, Tong-Tong Pei, Dong-Sheng |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Gong, Chan-Chan Li, Tong-Tong Pei, Dong-Sheng |
dc.subject.por.fl_str_mv |
PAK6 androgen Receptor (AR) cancer therapy miRNAs |
topic |
PAK6 androgen Receptor (AR) cancer therapy miRNAs |
description |
p21-activated kinase 6 (PAK6) is a member of the PAK family of serine/threonine kinases that are known effectors of Rho GTPases Cdc42 and Rac. PAKs regulate a large number of complex cellular mechanisms, including cell motility, morphology, and tumor development. PAK6, initially cloned as an interacting partner of the androgen receptor (AR), is associated with an array of cellular processes implicated in tumor progression. However, the full biological implications of PAK6 activity during cancer remain poorly understood. In this review, we assess our current understanding of the physiological roles of classical PAK6 functionality in mammals, in addition to its emerging role in tumorigenesis. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/182720 10.1590/s2175-97902019000318315 |
url |
https://www.revistas.usp.br/bjps/article/view/182720 |
identifier_str_mv |
10.1590/s2175-97902019000318315 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/182720/169583 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18315 Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18315 Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18315 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222915572006912 |